New strategy may enable cancer monitoring from blood tests alone

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment.

When protective lipids decline, health risks increase

New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes – not the presence of certain fats, but their suppression.

Religious leaders, physicians fight hypertension in Tanzania and beyond

Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.

Reprogramming gut cells to treat short bowel syndrome

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine; Weill Cornell investigators showed that this reversed the malnutrition that results when most of the small intestine is removed.

Hitting the target: Imaging reveals psilocybin’s neural odyssey

Cornell researchers have identified a pair of key neurological mechanisms in the brain – a cell type and receptor – that enable the psychedelic compound’s long-lasting effects.

Omega-6 fatty acid promotes growth of aggressive type of breast cancer

Linoleic acid enhances the growth of the hard-to-treat “triple negative” breast cancer subtype.

Pregnancy may reduce long COVID risk

Pregnancy may offer some protection from developing long COVID, found a new study led by Weill Cornell Medicine, University of Rochester Medical Center, University of Utah Health and Louisiana Public Health Institute.

AI meets oncology: New model personalizes bladder cancer treatment

Researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.

Weill Family Foundation’s $50M gift establishes Weill Cancer Hub East

Four leading research institutions, including Weill Cornell Medicine, have united under the Weill Cancer Hub East, an innovative, collaborative partnership that aims to transform cancer treatment.